Related references
Note: Only part of the references are listed.Assessment of Comorbidity Burden and Treatment Response: Reanalysis of the SCD-HEFT Trial
Emma C. Hegwood et al.
DRUGS & AGING (2022)
Predicted bene it of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score
Arwa Younis et al.
EUROPEAN HEART JOURNAL (2021)
Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models
Sarwar I. Mozumder et al.
BMC MEDICAL RESEARCH METHODOLOGY (2021)
Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD)
Tal Hasin et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
James P. Curtain et al.
EUROPEAN HEART JOURNAL (2021)
Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials
Jorge Romero et al.
EUROPACE (2018)
An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use
Keri L. Calkins et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death POST SCD Study
Zian H. Tseng et al.
CIRCULATION (2018)
Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices
Carlos de Diego et al.
HEART RHYTHM (2018)
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Sana M. Al-Khatib et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment
Aafke C. van der Heijden et al.
EUROPACE (2017)
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Kenneth C. Bilchick et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Declining Risk of Sudden Death in Heart Failure
Li Shen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
Lars Kober et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model
Ramin Shadman et al.
HEART RHYTHM (2015)
Application of the Multicenter Automatic Defibrillator Implantation Trial II Risk Score in a Nontrial Setting
Niyada Naksuk et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Applicability of a Risk Score for Prediction of the Long-Term (8-Year) Benefit of the Implantable Cardioverter-Defibrillator
Alon Barsheshet et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Reduction in Inappropriate Therapy and Mortality through ICD Programming
Arthur J. Moss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk stratification for primary implantation of a Cardioverter-Defibrillator in patients with ischemic left ventricular dysfunction
Ilan Goldenberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients - Results from the PREPARE (Primary Prevention Parameters Evaluation) study
Bruce L. Wilkoff et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The Seattle heart failure model - Prediction of survival in heart failure
WC Levy et al.
CIRCULATION (2006)
The effect of cardiac resynchronization on morbidity and mortality in heart failure
JGF Cleland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
GH Bardy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators - Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results
MS Wathen et al.
CIRCULATION (2004)
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
AJ Moss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
